These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11072274)
21. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning]. Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425 [TBL] [Abstract][Full Text] [Related]
22. [Neurohormonal factors in congestive heart failure]. Hannedouche T; Fournier JF Ann Med Interne (Paris); 1987; 138(2):123-9. PubMed ID: 3555207 [TBL] [Abstract][Full Text] [Related]
23. Congestive heart failure and renal complications. Del Rio-Santiago VJ; Rodriguez-Ospina L; Córdova HR; Vicenty SI Bol Asoc Med P R; 2008; 100(4):29-37. PubMed ID: 19400527 [TBL] [Abstract][Full Text] [Related]
24. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact. Jorde UP Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245 [TBL] [Abstract][Full Text] [Related]
25. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence. Dulin BR; Krum H Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210 [TBL] [Abstract][Full Text] [Related]
26. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348 [TBL] [Abstract][Full Text] [Related]
27. Spironolactone in left-sided heart failure: how does it fit in? Margo KL; Luttermoser G; Shaughnessy AF Am Fam Physician; 2001 Oct; 64(8):1393-8. PubMed ID: 11681781 [TBL] [Abstract][Full Text] [Related]
28. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function. Giles TD Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666 [TBL] [Abstract][Full Text] [Related]
29. [The process of drug development. The "case" of spironolactone]. De Feo S; Opasich C; Volpi A; Tavazzi L Ital Heart J Suppl; 2002 Feb; 3(2):178-86. PubMed ID: 11926024 [TBL] [Abstract][Full Text] [Related]
31. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic]. Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474 [TBL] [Abstract][Full Text] [Related]
32. [Activation of the renin-angiotensin-aldosterone system in heart failure]. Volpe M; Tocci G; Pagannone E Ital Heart J; 2005 May; 6 Suppl 1():16S-23S. PubMed ID: 15945296 [TBL] [Abstract][Full Text] [Related]
33. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046 [TBL] [Abstract][Full Text] [Related]
38. New strategies for improving heart failure management: a primary care perspective. Basile J South Med J; 2001 Feb; 94(2):166-74. PubMed ID: 11235030 [TBL] [Abstract][Full Text] [Related]
39. Acute decompensated heart failure: best evidence and current practice. Mehta R; Feldman D Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237 [TBL] [Abstract][Full Text] [Related]
40. The sympathetic nervous system and pathophysiology of congestive heart failure. Farmer J Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):6-11. PubMed ID: 19667705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]